Microdosing

Safety is Sexy in Healthcare B2B Sales; Why Risk, Not Upside, Decides Deals

March 3, 2026·13 min
Episode Description from the Publisher

In healthcare B2B sales, the deal is often shaped before ROI is fully debated. It begins when a buyer asks a simpler question: what could go wrong?Healthcare sales is methodical, slow, and process heavy. Health systems are not optimized for novelty or speed alone. They are optimized to avoid harm while maintaining continuity of care. Safety may not sound exciting, but for anyone selling into a hospital or large health system, it is often where deals gain or lose momentum.Buyers are not primarily asking how much upside a solution creates. They are asking how much risk it introduces. That does not mean upside is irrelevant. It means upside is filtered through a risk lens.

Podzilla Summary coming soon

Sign up to get notified when the full AI-powered summary is ready.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Listen to This Episode

Get summaries like this every morning.

Free AI-powered recaps of Microdosing and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.